Literature DB >> 217007

Lack of correlation between tumorigenicity and level of plasminogen activator in fibroblasts transformed by Rous sarcoma virus.

B A Wolf, A R Goldberg.   

Abstract

We have previously isolated, from agar suspension culture, clones of chicken embryo fibroblasts transformed by B77 and Prague strains of Rous sarcoma virus (RSV) that varied in the expression of plasminogen activator activity [Wolf, B. A. & Goldberg, A. (1976) Proc. Natl. Acad. Sci. USA 73, 3613-3617]. All of the clones exhibited an altered cellular morphology, an increased rate of sugar transport, and a high efficiency of colony formation in agar suspension regardless of the level of plasminogen activator. Because B77 and Prague strains of RSV replicate as well as cause sarcomas in chickens, the tumorigenicity of the transformed cells could not be evaluated with clones of these cells. In order to determine the oncogenicity of clones with various levels of plasminogen activator, it was necessary to isolate cells transformed by the replication-defective Bryan strain of RSV, which release noninfectious virus. All of the agar suspension clones of transformed cells, derived by infection of chicken embryo cells with replication-defective Bryan RSV, fell within the continuum observed for B77- and Prague-transformed clones with respect to altered morphology, increased rate of sugar transport, efficiency of colony formation in agar suspension, and variations in plasminogen activator activity. All of the clones, regardless of the level of plasminogen activator, produced tumors when as few as 5 x 10(2) cells were injected into the wing web of 1-day-old chicks. The latency period for tumor formation after injection of cells was similar regardless of the level of plasminogen activator of the injected cell. Primary explants of tumors resulting from inoculation of clones having low, intermediate, or high activator activity displayed a spectrum of activator activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 217007      PMCID: PMC336243          DOI: 10.1073/pnas.75.10.4967

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  ANALYSIS OF THE DEFECTIVENESS OF ROUS SARCOMA VIRUS, II. SPECIFICATION OF RSV ANTIGENICITY BY HELPER VIRUS.

Authors:  H HANAFUSA; T HANAFUSA; H RUBIN
Journal:  Proc Natl Acad Sci U S A       Date:  1964-01       Impact factor: 11.205

2.  The defectiveness of Rous sarcoma virus.

Authors:  H HANAFUSA; T HANAFUSA; H RUBIN
Journal:  Proc Natl Acad Sci U S A       Date:  1963-04       Impact factor: 11.205

3.  Induction of mutations in an RNA tumour virus by an analogue of a DNA precursor.

Authors:  J P Bader; N R Brown
Journal:  Nat New Biol       Date:  1971-11-03

4.  Differences between the ribonucleic acids of transforming and nontransforming avian tumor viruses.

Authors:  P H Duesberg; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

5.  Conditional lethal mutants of avian sarcoma viruses. I. Physiology of ts 75 and ts 149.

Authors:  R R Friis; K Toyoshima; P K Vogt
Journal:  Virology       Date:  1971-02       Impact factor: 3.616

6.  Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium.

Authors:  V H Freedman; S I Shin
Journal:  Cell       Date:  1974-12       Impact factor: 41.582

7.  Proteolytic enzymes initiating cell division and escape from contact inhibition of growth.

Authors:  M M Burger
Journal:  Nature       Date:  1970-07-11       Impact factor: 49.962

8.  Release from density dependent growth inhibition by proteolytic enzymes.

Authors:  B M Sefton; H Rubin
Journal:  Nature       Date:  1970-08-22       Impact factor: 49.962

9.  Fibrinolytic activity in a human fibrosarcoma cell line and evidence for the induction of plasminogen activator secretion during tumor formation.

Authors:  P A Jones; W E Laug; W F Benedict
Journal:  Cell       Date:  1975-10       Impact factor: 41.582

10.  Rous-sarcoma-virus-transformed fibroblasts having low levels of plasminogen activator.

Authors:  B A Wolf; A R Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

View more
  6 in total

1.  Morphological revertants of an avian sarcoma virus-transformed mammalian cell line exhibit tumorigenicity and contain pp60src.

Authors:  A F Lau; R A Krzyzek; J S Brugge; R L Erikson; J Schollmeyer; A J Faras
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

2.  Proteolytic and metastatic activities of clones derived from a methylcholanthrene-induced murine fibrosarcoma.

Authors:  M E McLaughlin; I E Liener; N Wang
Journal:  Clin Exp Metastasis       Date:  1983 Oct-Dec       Impact factor: 5.150

3.  Distinct transformation phenotypes induced by polyoma virus and simian virus 40 in rat fibroblasts and their control by an early viral gene function.

Authors:  B Perbal; M Rassoulzadegan
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

4.  Nontumoral, benign ad malignant stages of transformation of a diploid pig cell line. A review.

Authors:  A M Bouillant; P Genest; A S Greig
Journal:  Can J Comp Med       Date:  1981-07

5.  Tumorigenicity of herpesvirus-transformed cells correlates with production of plasminogen activator.

Authors:  S F Adelman; M K Howett; F Rapp
Journal:  Mol Cell Biol       Date:  1981-05       Impact factor: 4.272

6.  Regulation of plasminogen activator in 3T3 cells: effect of phorbol myristate acetate on subcellular distribution and molecular weight.

Authors:  S Jaken; P H Black
Journal:  J Cell Biol       Date:  1981-09       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.